Global Crohn’s Disease Diagnostic and Therapeutic Market Growth (Status and Outlook) 2024-2030

Product Code: 964919

Industry: Medical Care

Published: Jan 10,2024

Pages: 94

Delivery Time: 2-3 business days

Global Crohn’s Disease Diagnostic and Therapeutic Market Growth (Status and Outlook) 2024-2030

Product Code: 964919

Industry: Medical Care

Published: Jan 10,2024

Pages: 94

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

According to our LPI (LP Information) latest study, the global Crohn’s Disease Diagnostic and Therapeutic market size was valued at US$ million in 2023. With growing demand in downstream market, the Crohn’s Disease Diagnostic and Therapeutic is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global Crohn’s Disease Diagnostic and Therapeutic market.  Crohn’s Disease Diagnostic and Therapeutic are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Crohn’s Disease Diagnostic and Therapeutic. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Crohn’s Disease Diagnostic and Therapeutic market.

Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract from mouth to the anus. It is caused by a combination of environmental, immune, and bacterial factors, in genetically predisposed individuals.

This market is closely related to the pharmaceutical market.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Key Features:
The report on Crohn’s Disease Diagnostic and Therapeutic market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Crohn’s Disease Diagnostic and Therapeutic market. It may include historical data, market segmentation by Type (e.g., Diagnostics, Treatment), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Crohn’s Disease Diagnostic and Therapeutic market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Crohn’s Disease Diagnostic and Therapeutic market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Crohn’s Disease Diagnostic and Therapeutic industry. This include advancements in Crohn’s Disease Diagnostic and Therapeutic technology, Crohn’s Disease Diagnostic and Therapeutic new entrants, Crohn’s Disease Diagnostic and Therapeutic new investment, and other innovations that are shaping the future of Crohn’s Disease Diagnostic and Therapeutic.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Crohn’s Disease Diagnostic and Therapeutic market. It includes factors influencing customer ' purchasing decisions, preferences for Crohn’s Disease Diagnostic and Therapeutic product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Crohn’s Disease Diagnostic and Therapeutic market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Crohn’s Disease Diagnostic and Therapeutic market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Crohn’s Disease Diagnostic and Therapeutic market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Crohn’s Disease Diagnostic and Therapeutic industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Crohn’s Disease Diagnostic and Therapeutic market.

Market Segmentation:
Crohn’s Disease Diagnostic and Therapeutic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
Diagnostics
Treatment

Segmentation by application
Hospital
Medical Research Institute
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Abbvie
Celgene
Genetech
Johnson & Johnson
Pfizer
Prometheus Laboratories
Salix Pharmaceuticals
Takeda Pharmaceutical

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Size 2019-2030
        2.1.2 Crohn’s Disease Diagnostic and Therapeutic Market Size CAGR by Region 2019 VS 2023 VS 2030
    2.2 Crohn’s Disease Diagnostic and Therapeutic Segment by Type
        2.2.1 Diagnostics
        2.2.2 Treatment
    2.3 Crohn’s Disease Diagnostic and Therapeutic Market Size by Type
        2.3.1 Crohn’s Disease Diagnostic and Therapeutic Market Size CAGR by Type (2019 VS 2023 VS 2030)
        2.3.2 Global Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Type (2019-2024)
    2.4 Crohn’s Disease Diagnostic and Therapeutic Segment by Application
        2.4.1 Hospital
        2.4.2 Medical Research Institute
        2.4.3 Other
    2.5 Crohn’s Disease Diagnostic and Therapeutic Market Size by Application
        2.5.1 Crohn’s Disease Diagnostic and Therapeutic Market Size CAGR by Application (2019 VS 2023 VS 2030)
        2.5.2 Global Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Application (2019-2024)

3 Crohn’s Disease Diagnostic and Therapeutic Market Size by Player
    3.1 Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Players
        3.1.1 Global Crohn’s Disease Diagnostic and Therapeutic Revenue by Players (2019-2024)
        3.1.2 Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Players (2019-2024)
    3.2 Global Crohn’s Disease Diagnostic and Therapeutic Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Crohn’s Disease Diagnostic and Therapeutic by Regions
    4.1 Crohn’s Disease Diagnostic and Therapeutic Market Size by Regions (2019-2024)
    4.2 Americas Crohn’s Disease Diagnostic and Therapeutic Market Size Growth (2019-2024)
    4.3 APAC Crohn’s Disease Diagnostic and Therapeutic Market Size Growth (2019-2024)
    4.4 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size Growth (2019-2024)
    4.5 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size Growth (2019-2024)

5 Americas
    5.1 Americas Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2019-2024)
    5.2 Americas Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2019-2024)
    5.3 Americas Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2019-2024)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2019-2024)
    6.2 APAC Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2019-2024)
    6.3 APAC Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2019-2024)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Crohn’s Disease Diagnostic and Therapeutic by Country (2019-2024)
    7.2 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2019-2024)
    7.3 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2019-2024)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic by Region (2019-2024)
    8.2 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2019-2024)
    8.3 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2019-2024)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Global Crohn’s Disease Diagnostic and Therapeutic Market Forecast
    10.1 Global Crohn’s Disease Diagnostic and Therapeutic Forecast by Regions (2025-2030)
        10.1.1 Global Crohn’s Disease Diagnostic and Therapeutic Forecast by Regions (2025-2030)
        10.1.2 Americas Crohn’s Disease Diagnostic and Therapeutic Forecast
        10.1.3 APAC Crohn’s Disease Diagnostic and Therapeutic Forecast
        10.1.4 Europe Crohn’s Disease Diagnostic and Therapeutic Forecast
        10.1.5 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Forecast
    10.2 Americas Crohn’s Disease Diagnostic and Therapeutic Forecast by Country (2025-2030)
        10.2.1 United States Crohn’s Disease Diagnostic and Therapeutic Market Forecast
        10.2.2 Canada Crohn’s Disease Diagnostic and Therapeutic Market Forecast
        10.2.3 Mexico Crohn’s Disease Diagnostic and Therapeutic Market Forecast
        10.2.4 Brazil Crohn’s Disease Diagnostic and Therapeutic Market Forecast
    10.3 APAC Crohn’s Disease Diagnostic and Therapeutic Forecast by Region (2025-2030)
        10.3.1 China Crohn’s Disease Diagnostic and Therapeutic Market Forecast
        10.3.2 Japan Crohn’s Disease Diagnostic and Therapeutic Market Forecast
        10.3.3 Korea Crohn’s Disease Diagnostic and Therapeutic Market Forecast
        10.3.4 Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Forecast
        10.3.5 India Crohn’s Disease Diagnostic and Therapeutic Market Forecast
        10.3.6 Australia Crohn’s Disease Diagnostic and Therapeutic Market Forecast
    10.4 Europe Crohn’s Disease Diagnostic and Therapeutic Forecast by Country (2025-2030)
        10.4.1 Germany Crohn’s Disease Diagnostic and Therapeutic Market Forecast
        10.4.2 France Crohn’s Disease Diagnostic and Therapeutic Market Forecast
        10.4.3 UK Crohn’s Disease Diagnostic and Therapeutic Market Forecast
        10.4.4 Italy Crohn’s Disease Diagnostic and Therapeutic Market Forecast
        10.4.5 Russia Crohn’s Disease Diagnostic and Therapeutic Market Forecast
    10.5 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Forecast by Region (2025-2030)
        10.5.1 Egypt Crohn’s Disease Diagnostic and Therapeutic Market Forecast
        10.5.2 South Africa Crohn’s Disease Diagnostic and Therapeutic Market Forecast
        10.5.3 Israel Crohn’s Disease Diagnostic and Therapeutic Market Forecast
        10.5.4 Turkey Crohn’s Disease Diagnostic and Therapeutic Market Forecast
        10.5.5 GCC Countries Crohn’s Disease Diagnostic and Therapeutic Market Forecast
    10.6 Global Crohn’s Disease Diagnostic and Therapeutic Forecast by Type (2025-2030)
    10.7 Global Crohn’s Disease Diagnostic and Therapeutic Forecast by Application (2025-2030)

11 Key Players Analysis
    11.1 Abbvie
        11.1.1 Abbvie Company Information
        11.1.2 Abbvie Crohn’s Disease Diagnostic and Therapeutic Product Offered
        11.1.3 Abbvie Crohn’s Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
        11.1.4 Abbvie Main Business Overview
        11.1.5 Abbvie Latest Developments
    11.2 Celgene
        11.2.1 Celgene Company Information
        11.2.2 Celgene Crohn’s Disease Diagnostic and Therapeutic Product Offered
        11.2.3 Celgene Crohn’s Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
        11.2.4 Celgene Main Business Overview
        11.2.5 Celgene Latest Developments
    11.3 Genetech
        11.3.1 Genetech Company Information
        11.3.2 Genetech Crohn’s Disease Diagnostic and Therapeutic Product Offered
        11.3.3 Genetech Crohn’s Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
        11.3.4 Genetech Main Business Overview
        11.3.5 Genetech Latest Developments
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Information
        11.4.2 Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Product Offered
        11.4.3 Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
        11.4.4 Johnson & Johnson Main Business Overview
        11.4.5 Johnson & Johnson Latest Developments
    11.5 Pfizer
        11.5.1 Pfizer Company Information
        11.5.2 Pfizer Crohn’s Disease Diagnostic and Therapeutic Product Offered
        11.5.3 Pfizer Crohn’s Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
        11.5.4 Pfizer Main Business Overview
        11.5.5 Pfizer Latest Developments
    11.6 Prometheus Laboratories
        11.6.1 Prometheus Laboratories Company Information
        11.6.2 Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Product Offered
        11.6.3 Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
        11.6.4 Prometheus Laboratories Main Business Overview
        11.6.5 Prometheus Laboratories Latest Developments
    11.7 Salix Pharmaceuticals
        11.7.1 Salix Pharmaceuticals Company Information
        11.7.2 Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Product Offered
        11.7.3 Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
        11.7.4 Salix Pharmaceuticals Main Business Overview
        11.7.5 Salix Pharmaceuticals Latest Developments
    11.8 Takeda Pharmaceutical
        11.8.1 Takeda Pharmaceutical Company Information
        11.8.2 Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Product Offered
        11.8.3 Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
        11.8.4 Takeda Pharmaceutical Main Business Overview
        11.8.5 Takeda Pharmaceutical Latest Developments

12 Research Findings and Conclusion

List Of Tables

List of Tables
    Table 1. Crohn’s Disease Diagnostic and Therapeutic Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
    Table 2. Major Players of Diagnostics
    Table 3. Major Players of Treatment
    Table 4. Crohn’s Disease Diagnostic and Therapeutic Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
    Table 5. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2019-2024) & ($ Millions)
    Table 6. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Type (2019-2024)
    Table 7. Crohn’s Disease Diagnostic and Therapeutic Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
    Table 8. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2019-2024) & ($ Millions)
    Table 9. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Application (2019-2024)
    Table 10. Global Crohn’s Disease Diagnostic and Therapeutic Revenue by Players (2019-2024) & ($ Millions)
    Table 11. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Player (2019-2024)
    Table 12. Crohn’s Disease Diagnostic and Therapeutic Key Players Head office and Products Offered
    Table 13. Crohn’s Disease Diagnostic and Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
    Table 14. New Products and Potential Entrants
    Table 15. Mergers & Acquisitions, Expansion
    Table 16. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Regions 2019-2024 & ($ Millions)
    Table 17. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Regions (2019-2024)
    Table 18. Global Crohn’s Disease Diagnostic and Therapeutic Revenue by Country/Region (2019-2024) & ($ millions)
    Table 19. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Country/Region (2019-2024)
    Table 20. Americas Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2019-2024) & ($ Millions)
    Table 21. Americas Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Country (2019-2024)
    Table 22. Americas Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2019-2024) & ($ Millions)
    Table 23. Americas Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Type (2019-2024)
    Table 24. Americas Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2019-2024) & ($ Millions)
    Table 25. Americas Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Application (2019-2024)
    Table 26. APAC Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2019-2024) & ($ Millions)
    Table 27. APAC Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Region (2019-2024)
    Table 28. APAC Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2019-2024) & ($ Millions)
    Table 29. APAC Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Type (2019-2024)
    Table 30. APAC Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2019-2024) & ($ Millions)
    Table 31. APAC Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Application (2019-2024)
    Table 32. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2019-2024) & ($ Millions)
    Table 33. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Country (2019-2024)
    Table 34. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2019-2024) & ($ Millions)
    Table 35. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Type (2019-2024)
    Table 36. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2019-2024) & ($ Millions)
    Table 37. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Application (2019-2024)
    Table 38. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2019-2024) & ($ Millions)
    Table 39. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Region (2019-2024)
    Table 40. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2019-2024) & ($ Millions)
    Table 41. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Type (2019-2024)
    Table 42. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2019-2024) & ($ Millions)
    Table 43. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Application (2019-2024)
    Table 44. Key Market Drivers & Growth Opportunities of Crohn’s Disease Diagnostic and Therapeutic
    Table 45. Key Market Challenges & Risks of Crohn’s Disease Diagnostic and Therapeutic
    Table 46. Key Industry Trends of Crohn’s Disease Diagnostic and Therapeutic
    Table 47. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Forecast by Regions (2025-2030) & ($ Millions)
    Table 48. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share Forecast by Regions (2025-2030)
    Table 49. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Forecast by Type (2025-2030) & ($ Millions)
    Table 50. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Forecast by Application (2025-2030) & ($ Millions)
    Table 51. Abbvie Details, Company Type, Crohn’s Disease Diagnostic and Therapeutic Area Served and Its Competitors
    Table 52. Abbvie Crohn’s Disease Diagnostic and Therapeutic Product Offered
    Table 53. Abbvie Crohn’s Disease Diagnostic and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 54. Abbvie Main Business
    Table 55. Abbvie Latest Developments
    Table 56. Celgene Details, Company Type, Crohn’s Disease Diagnostic and Therapeutic Area Served and Its Competitors
    Table 57. Celgene Crohn’s Disease Diagnostic and Therapeutic Product Offered
    Table 58. Celgene Main Business
    Table 59. Celgene Crohn’s Disease Diagnostic and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 60. Celgene Latest Developments
    Table 61. Genetech Details, Company Type, Crohn’s Disease Diagnostic and Therapeutic Area Served and Its Competitors
    Table 62. Genetech Crohn’s Disease Diagnostic and Therapeutic Product Offered
    Table 63. Genetech Main Business
    Table 64. Genetech Crohn’s Disease Diagnostic and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 65. Genetech Latest Developments
    Table 66. Johnson & Johnson Details, Company Type, Crohn’s Disease Diagnostic and Therapeutic Area Served and Its Competitors
    Table 67. Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Product Offered
    Table 68. Johnson & Johnson Main Business
    Table 69. Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 70. Johnson & Johnson Latest Developments
    Table 71. Pfizer Details, Company Type, Crohn’s Disease Diagnostic and Therapeutic Area Served and Its Competitors
    Table 72. Pfizer Crohn’s Disease Diagnostic and Therapeutic Product Offered
    Table 73. Pfizer Main Business
    Table 74. Pfizer Crohn’s Disease Diagnostic and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 75. Pfizer Latest Developments
    Table 76. Prometheus Laboratories Details, Company Type, Crohn’s Disease Diagnostic and Therapeutic Area Served and Its Competitors
    Table 77. Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Product Offered
    Table 78. Prometheus Laboratories Main Business
    Table 79. Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 80. Prometheus Laboratories Latest Developments
    Table 81. Salix Pharmaceuticals Details, Company Type, Crohn’s Disease Diagnostic and Therapeutic Area Served and Its Competitors
    Table 82. Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Product Offered
    Table 83. Salix Pharmaceuticals Main Business
    Table 84. Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 85. Salix Pharmaceuticals Latest Developments
    Table 86. Takeda Pharmaceutical Details, Company Type, Crohn’s Disease Diagnostic and Therapeutic Area Served and Its Competitors
    Table 87. Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Product Offered
    Table 88. Takeda Pharmaceutical Main Business
    Table 89. Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 90. Takeda Pharmaceutical Latest Developments
List of Figures
    Figure 1. Crohn’s Disease Diagnostic and Therapeutic Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate 2019-2030 ($ Millions)
    Figure 6. Crohn’s Disease Diagnostic and Therapeutic Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
    Figure 7. Crohn’s Disease Diagnostic and Therapeutic Sales Market Share by Country/Region (2023)
    Figure 8. Crohn’s Disease Diagnostic and Therapeutic Sales Market Share by Country/Region (2019, 2023 & 2030)
    Figure 9. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Type in 2023
    Figure 10. Crohn’s Disease Diagnostic and Therapeutic in Hospital
    Figure 11. Global Crohn’s Disease Diagnostic and Therapeutic Market: Hospital (2019-2024) & ($ Millions)
    Figure 12. Crohn’s Disease Diagnostic and Therapeutic in Medical Research Institute
    Figure 13. Global Crohn’s Disease Diagnostic and Therapeutic Market: Medical Research Institute (2019-2024) & ($ Millions)
    Figure 14. Crohn’s Disease Diagnostic and Therapeutic in Other
    Figure 15. Global Crohn’s Disease Diagnostic and Therapeutic Market: Other (2019-2024) & ($ Millions)
    Figure 16. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Application in 2023
    Figure 17. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Player in 2023
    Figure 18. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Regions (2019-2024)
    Figure 19. Americas Crohn’s Disease Diagnostic and Therapeutic Market Size 2019-2024 ($ Millions)
    Figure 20. APAC Crohn’s Disease Diagnostic and Therapeutic Market Size 2019-2024 ($ Millions)
    Figure 21. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size 2019-2024 ($ Millions)
    Figure 22. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size 2019-2024 ($ Millions)
    Figure 23. Americas Crohn’s Disease Diagnostic and Therapeutic Value Market Share by Country in 2023
    Figure 24. United States Crohn’s Disease Diagnostic and Therapeutic Market Size Growth 2019-2024 ($ Millions)
    Figure 25. Canada Crohn’s Disease Diagnostic and Therapeutic Market Size Growth 2019-2024 ($ Millions)
    Figure 26. Mexico Crohn’s Disease Diagnostic and Therapeutic Market Size Growth 2019-2024 ($ Millions)
    Figure 27. Brazil Crohn’s Disease Diagnostic and Therapeutic Market Size Growth 2019-2024 ($ Millions)
    Figure 28. APAC Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Region in 2023
    Figure 29. APAC Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Type in 2023
    Figure 30. APAC Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Application in 2023
    Figure 31. China Crohn’s Disease Diagnostic and Therapeutic Market Size Growth 2019-2024 ($ Millions)
    Figure 32. Japan Crohn’s Disease Diagnostic and Therapeutic Market Size Growth 2019-2024 ($ Millions)
    Figure 33. Korea Crohn’s Disease Diagnostic and Therapeutic Market Size Growth 2019-2024 ($ Millions)
    Figure 34. Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size Growth 2019-2024 ($ Millions)
    Figure 35. India Crohn’s Disease Diagnostic and Therapeutic Market Size Growth 2019-2024 ($ Millions)
    Figure 36. Australia Crohn’s Disease Diagnostic and Therapeutic Market Size Growth 2019-2024 ($ Millions)
    Figure 37. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Country in 2023
    Figure 38. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Type (2019-2024)
    Figure 39. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Application (2019-2024)
    Figure 40. Germany Crohn’s Disease Diagnostic and Therapeutic Market Size Growth 2019-2024 ($ Millions)
    Figure 41. France Crohn’s Disease Diagnostic and Therapeutic Market Size Growth 2019-2024 ($ Millions)
    Figure 42. UK Crohn’s Disease Diagnostic and Therapeutic Market Size Growth 2019-2024 ($ Millions)
    Figure 43. Italy Crohn’s Disease Diagnostic and Therapeutic Market Size Growth 2019-2024 ($ Millions)
    Figure 44. Russia Crohn’s Disease Diagnostic and Therapeutic Market Size Growth 2019-2024 ($ Millions)
    Figure 45. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Region (2019-2024)
    Figure 46. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Type (2019-2024)
    Figure 47. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share by Application (2019-2024)
    Figure 48. Egypt Crohn’s Disease Diagnostic and Therapeutic Market Size Growth 2019-2024 ($ Millions)
    Figure 49. South Africa Crohn’s Disease Diagnostic and Therapeutic Market Size Growth 2019-2024 ($ Millions)
    Figure 50. Israel Crohn’s Disease Diagnostic and Therapeutic Market Size Growth 2019-2024 ($ Millions)
    Figure 51. Turkey Crohn’s Disease Diagnostic and Therapeutic Market Size Growth 2019-2024 ($ Millions)
    Figure 52. GCC Country Crohn’s Disease Diagnostic and Therapeutic Market Size Growth 2019-2024 ($ Millions)
    Figure 53. Americas Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 54. APAC Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 55. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 56. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 57. United States Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 58. Canada Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 59. Mexico Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 60. Brazil Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 61. China Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 62. Japan Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 63. Korea Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 64. Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 65. India Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 66. Australia Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 67. Germany Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 68. France Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 69. UK Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 70. Italy Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 71. Russia Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 72. Spain Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 73. Egypt Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 74. South Africa Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 75. Israel Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 76. Turkey Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 77. GCC Countries Crohn’s Disease Diagnostic and Therapeutic Market Size 2025-2030 ($ Millions)
    Figure 78. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share Forecast by Type (2025-2030)
    Figure 79. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Market Share Forecast by Application (2025-2030)

Companies Mentioned

Abbvie

Celgene

Genetech

Johnson & Johnson

Pfizer

Prometheus Laboratories

Salix Pharmaceuticals

Takeda Pharmaceutical

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff